ciprofloxacin has been researched along with Complications of Diabetes Mellitus in 25 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to assess the pharmacokinetic profile of ciprofloxacin in 12 patients with diabetic gastroparesis." | 9.08 | Absorption of ciprofloxacin in patients with diabetic gastroparesis. ( Bassaris, HP; Marangos, MN; Nicolau, DP; Nightingale, CH; Psyrogiannis, AG; Quintiliani, R; Skoutelis, AT; Zhu, Z, 1995) |
| "Forty-eight patients with peripheral vascular disease (46 with diabetes mellitus) who presented to the hospital for treatment of lower extremity infections were randomized in a blinded fashion to receive oral ciprofloxacin at a dosage of either 750 mg or 1,000 mg twice daily." | 9.06 | Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. ( Canter, K; Clabots, C; Fasching, CE; Gerding, DN; Lissack, LM; Peterson, LR, 1989) |
| "The purpose of this study was to assess the pharmacokinetic profile of ciprofloxacin in 12 patients with diabetic gastroparesis." | 5.08 | Absorption of ciprofloxacin in patients with diabetic gastroparesis. ( Bassaris, HP; Marangos, MN; Nicolau, DP; Nightingale, CH; Psyrogiannis, AG; Quintiliani, R; Skoutelis, AT; Zhu, Z, 1995) |
| "Forty-eight patients with peripheral vascular disease (46 with diabetes mellitus) who presented to the hospital for treatment of lower extremity infections were randomized in a blinded fashion to receive oral ciprofloxacin at a dosage of either 750 mg or 1,000 mg twice daily." | 5.06 | Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. ( Canter, K; Clabots, C; Fasching, CE; Gerding, DN; Lissack, LM; Peterson, LR, 1989) |
| " The risk of hypoglycemia varied according to the type of fluoroquinolone administered, and was most commonly associated with moxifloxacin." | 3.79 | Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan. ( Chang, CH; Chou, HW; Lai, MS; Lee, JJ; Shau, WY; Wang, JL, 2013) |
| "Ciprofloxacin was used in doses of 500 or 1000 mg orally once a day depending on the severity of the disease singns for 2-3 weeks as etiotropic therapy and only in 2 cases with severe pyelonephritis it was used intravenously drop-wise and orally simultaneously." | 2.71 | [Therapy of urinary tract infections in patients with diabetes mellitus]. ( Babarina, MB; Orlov, VA; Sokolova, VI, 2005) |
| "Ciprofloxacin was well tolerated, with the most frequent adverse reactions being rash, gastrointestinal intolerance, and increased levels of liver enzymes, each of which occurred in five patients." | 2.66 | Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics. ( Cumbo, TJ; DeVito, JM; Kuritzky, P; Nix, DE; Schentag, JJ, 1987) |
| "Endogenous endophthalmitis is a rare condition caused by the hematogenous spread of microorganisms from a remote infection site to the eye." | 1.42 | Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis. ( de Haller, R; Mavrakanas, TA; Philippe, J, 2015) |
| "Emphysematous cystitis is a very rare complicated urinary tract infection characterized by air in the bladder wall." | 1.42 | Emphysematous cystitis presenting as severe confusion and abdominal pain: two case reports. ( De Coninck, V; Michielsen, D, 2015) |
| "Necrotizing otitis externa is an uncommon but potentially life-threatening infection disease of the external auditory canal and temporal bone." | 1.37 | Differential diagnosis and treatments of necrotizing otitis externa: a report of 19 cases. ( Chan, KC; Chen, CK; Chen, YA; Wu, CM, 2011) |
| "We present a case of an infected abdominal aortic aneurysm due to Salmonella enteritidis." | 1.35 | F-18 FDG PET/CT in the management of infected abdominal aortic aneurysm due to Salmonella. ( Byun, SS; Cheong, MH; Choi, SJ; Hyun, IY; Lee, JS, 2008) |
| "Pneumococcal cellulitis is an uncommon infection." | 1.34 | [Streptococcus pneumoniae cellulitis in a diabetic patient]. ( Bouzat, P; Broux, C; Croizé, J; Jacquot, C; Pavese, P; Soriano, E; Stahl, JP, 2007) |
| "Even extensive malakoplakia can be successfully treated with ciprofloxacin." | 1.30 | [Malacoplakia: a possible complication of poorly controlled diabetes mellitus?]. ( Biesenbach, G; Eichbauer-Sturm, G; Grafinger, P; Höpfl, I; Janko, O; Syré, G, 1999) |
| "We report a patient with polycystic renal disease and diabetes mellitus who developed a urinary infection due to Salmonella enteritidis following presumed enteric infection." | 1.29 | Salmonella enteritidis urinary infection associated with polycystic renal disease. ( Douglas, JG; Laing, RB; Smith, FW, 1993) |
| " Therapy has traditionally consisted of the long-term administration of combination parenteral antibiotics, but morbidity and mortality remain substantial despite this therapy." | 1.28 | Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. ( Kamerer, DB; Matador, A; Muder, RR; Rubin, J; Stoehr, G; Yu, VL, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, HW | 1 |
| Wang, JL | 1 |
| Chang, CH | 1 |
| Lee, JJ | 1 |
| Shau, WY | 1 |
| Lai, MS | 1 |
| Tan, C | 1 |
| Zhang, LL | 1 |
| Min, ZS | 1 |
| Mavrakanas, TA | 1 |
| de Haller, R | 1 |
| Philippe, J | 1 |
| De Coninck, V | 1 |
| Michielsen, D | 1 |
| Choi, SJ | 1 |
| Lee, JS | 1 |
| Cheong, MH | 1 |
| Byun, SS | 1 |
| Hyun, IY | 1 |
| Chen, YA | 1 |
| Chan, KC | 1 |
| Chen, CK | 1 |
| Wu, CM | 1 |
| Akhaddar, A | 1 |
| Boulahroud, O | 1 |
| Boucetta, M | 1 |
| Batres Iglesias, AP | 1 |
| Pérez Cabeza, MI | 1 |
| Del Río Pardo, MJ | 1 |
| Castaño, M | 1 |
| Meiland, R | 1 |
| Geerlings, SE | 1 |
| De Neeling, AJ | 1 |
| Hoepelman, AI | 1 |
| Benenson, S | 1 |
| Yinnon, AM | 1 |
| Schlesinger, Y | 1 |
| Rudensky, B | 1 |
| Raveh, D | 1 |
| Djalilian, HR | 1 |
| Shamloo, B | 1 |
| Thakkar, KH | 1 |
| Najme-Rahim, M | 1 |
| Pertel, PE | 1 |
| Haverstock, D | 1 |
| Sokolova, VI | 1 |
| Orlov, VA | 1 |
| Babarina, MB | 1 |
| Bouzat, P | 1 |
| Broux, C | 1 |
| Soriano, E | 1 |
| Pavese, P | 1 |
| Croizé, J | 1 |
| Stahl, JP | 1 |
| Jacquot, C | 1 |
| Joshua, BZ | 1 |
| Sulkes, J | 1 |
| Raveh, E | 1 |
| Bishara, J | 1 |
| Nageris, BI | 1 |
| Laing, RB | 1 |
| Smith, FW | 1 |
| Douglas, JG | 1 |
| Marangos, MN | 1 |
| Skoutelis, AT | 1 |
| Nightingale, CH | 1 |
| Zhu, Z | 1 |
| Psyrogiannis, AG | 1 |
| Nicolau, DP | 1 |
| Bassaris, HP | 1 |
| Quintiliani, R | 1 |
| Eichbauer-Sturm, G | 1 |
| Janko, O | 1 |
| Grafinger, P | 1 |
| Höpfl, I | 1 |
| Syré, G | 1 |
| Biesenbach, G | 1 |
| Ghosh, SK | 1 |
| de Lalla, F | 1 |
| Pellizzer, G | 1 |
| Strazzabosco, M | 1 |
| Martini, Z | 1 |
| Du Jardin, G | 1 |
| Lora, L | 1 |
| Fabris, P | 1 |
| Benedetti, P | 1 |
| Erle, G | 1 |
| Sesin, GP | 1 |
| Paszko, A | 1 |
| O'Keefe, E | 1 |
| Rubin, J | 1 |
| Stoehr, G | 1 |
| Yu, VL | 1 |
| Muder, RR | 1 |
| Matador, A | 1 |
| Kamerer, DB | 1 |
| Peterson, LR | 1 |
| Lissack, LM | 1 |
| Canter, K | 1 |
| Fasching, CE | 1 |
| Clabots, C | 1 |
| Gerding, DN | 1 |
| Nix, DE | 1 |
| Cumbo, TJ | 1 |
| Kuritzky, P | 1 |
| DeVito, JM | 1 |
| Schentag, JJ | 1 |
| Pérez-Ruvalcaba, JA | 1 |
| Quintero-Pérez, NP | 1 |
| Morales-Reyes, JJ | 1 |
| Huitrón-Ramírez, JA | 1 |
| Rodríguez-Chagollán, JJ | 1 |
| Rodríguez-Noriega, E | 1 |
6 trials available for ciprofloxacin and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
[Therapy of urinary tract infections in patients with diabetes mellitus].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Delayed-Action Preparations; Di | 2005 |
Absorption of ciprofloxacin in patients with diabetic gastroparesis.
Topics: Adult; Aged; Biological Availability; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Fema | 1995 |
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.
Topics: Adjuvants, Immunologic; Adult; Aged; Amputation, Surgical; Anti-Bacterial Agents; Anti-Infective Age | 2001 |
Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both.
Topics: Adult; Bacteria; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Diabetes Complicatio | 1989 |
Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics.
Topics: Administration, Oral; Aged; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Diabetes | 1987 |
Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Cefotaxime; Ciprofloxacin; Clinical Trials | 1987 |
19 other studies available for ciprofloxacin and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cohort Studies; Diabet | 2013 |
Toe web malodorous maceration with well-demarcated punch-out edge.
Topics: Ciprofloxacin; Diabetes Complications; Humans; Intertrigo; Male; Middle Aged; Phytotherapy; Plant Ex | 2016 |
Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Endophthalmit | 2015 |
Emphysematous cystitis presenting as severe confusion and abdominal pain: two case reports.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Confusion; Cystitis; | 2015 |
F-18 FDG PET/CT in the management of infected abdominal aortic aneurysm due to Salmonella.
Topics: Aged; Anti-Infective Agents; Aortic Aneurysm, Abdominal; Ciprofloxacin; Diabetes Complications; Diag | 2008 |
Differential diagnosis and treatments of necrotizing otitis externa: a report of 19 cases.
Topics: Adult; Aged; Aged, 80 and over; Ciprofloxacin; Comorbidity; Diabetes Complications; Diagnosis, Diffe | 2011 |
Chronic spinal cord abscess in an elderly patient.
Topics: Abscess; Adrenal Cortex Hormones; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents | 2011 |
[Endogenous endophthalmitis as a first clinical manifestation of Klebsiella sepsis. The importance of an early diagnosis].
Topics: Anti-Bacterial Agents; Bacteremia; Chorioretinitis; Choroid Hemorrhage; Ciprofloxacin; Combined Moda | 2011 |
Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Diabetes Co | 2004 |
Optimization of empirical antibiotic selection for suspected Gram-negative bacteraemia in the emergency department.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Ciprofloxacin; Diabetes Co | 2005 |
Treatment of culture-negative skull base osteomyelitis.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aztreonam; Ceftazidi | 2006 |
Risk factors for a poor outcome after therapy for acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Diabetes | 2006 |
[Streptococcus pneumoniae cellulitis in a diabetic patient].
Topics: Aged; Ceftriaxone; Cellulitis; Ciprofloxacin; Diabetes Complications; Humans; Male; Metronidazole; M | 2007 |
Predicting outcome of malignant external otitis.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; | 2008 |
Salmonella enteritidis urinary infection associated with polycystic renal disease.
Topics: Ciprofloxacin; Diabetes Complications; Humans; Male; Middle Aged; Polycystic Kidney Diseases; Radion | 1993 |
[Malacoplakia: a possible complication of poorly controlled diabetes mellitus?].
Topics: Abdomen; Anti-Infective Agents; Biopsy; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Fe | 1999 |
A rare infection caused by Chryseomonas luteola.
Topics: Adult; Anti-Infective Agents; Anti-Infective Agents, Local; Chlorhexidine; Ciprofloxacin; Diabetes C | 2000 |
Oral clindamycin and ciprofloxacin therapy for diabetic foot infections.
Topics: Administration, Oral; Bacterial Infections; Ciprofloxacin; Clindamycin; Diabetes Complications; Drug | 1990 |
Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Diabetes Complic | 1989 |